Stage IIIA-N2 NSCLC: A review of its treatment approaches and future developmentsVAN MEERBEECK, Jan P; SURMONT, Veerle F. M.Lung cancer. 2009, Vol 65, Num 3, pp 257-267, issn 0169-5002, 11 p.Article

Novel treatment options in stage I non-small-cell lung cancerTARASEVYCH, Svitlana; LAUWERS, Patrick; VANDAELE, Frederik et al.Expert review of anticancer therapy. 2014, Vol 14, Num 9, pp 1007-1020, issn 1473-7140, 14 p.Article

Quantitative Perfusion Scintigraphy or Anatomic Segment Method in lung cancer resectionHOLVOET, Tom; VAN MEERBEECK, Jan P; VAN DE WIELE, Christophe et al.Lung cancer. 2011, Vol 74, Num 2, pp 212-218, issn 0169-5002, 7 p.Article

Malignant pleural mesothelioma: The standard of care and challenges for future managementVAN MEERBEECK, Jan P; SCHERPEREEL, Arnaud; SURMONT, Veerle F et al.Critical reviews in oncology/hematology. 2011, Vol 78, Num 2, pp 92-111, issn 1040-8428, 20 p.Article

Consensus report : Pretreatment minimal staging and treatment of potentially resectable malignant pleural mesotheliomaVAN MEERBEECK, Jan P; BOYER, Michael.Lung cancer. 2005, Vol 49, pp S123-S127, issn 0169-5002, SUP1Conference Paper

Small-cell lung cancerVAN MEERBEECK, Jan P; FENNELL, Dean A; DE RUYSSCHER, Dirk K. M et al.Lancet (British edition). 2011, Vol 378, Num 9804, pp 1741-1755, issn 0140-6736, 15 p.Article

The role of gemcitabine in the treatment of malignant mesotheliomaKINDLER, Hedy Lee; VAN MEERBEECK, Jan. P.Seminars in oncology. 2002, Vol 29, Num 1, pp 70-76, issn 0093-7754Article

Esophageal endoscopic ultrasound with fine-needle aspiration with an on-site cytopathologist : High accuracy for the diagnosis of mediastinal lymphadenopathyTOURNOY, Kurt G; PRAET, Marleen M; VAN MAELE, Georges et al.Chest. 2005, Vol 128, Num 4, pp 3004-3009, issn 0012-3692, 6 p.Article

Economic evaluation of three two-drug chemotherapy regimens in advanced non-small-cell lung cancerNEYMARK, Niels; LIANES, Pilar; SMIT, Egbert F et al.PharmacoEconomics (Auckland). 2005, Vol 23, Num 11, pp 1155-1166, issn 1170-7690, 12 p.Article

Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesotheliomaVAN KLAVEREN, Rob J; AERTS, Joachim G. J. V; DE BRUIN, Hein et al.Lung cancer. 2004, Vol 43, Num 1, pp 63-69, issn 0169-5002, 7 p.Article

The Sound of the Parasite. Diagnosing Mediastinal Cysts with Endoscopic Ultrasound TechniquesTOURNOY, Kurt G; ROMBAUT, Bart; GOEMINNE, Hannelore et al.Respiration (Basel). 2008, Vol 75, Num 1, pp 98-99, issn 0025-7931, 2 p.Article

Symptoms and Patient-Reported Well-Being: Do They Predict Survival in Malignant Pleural Mesothelioma? A Prognostic Factor Analysis of EORTC-NCIC 08983 : Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural MesotheliomaBOTTOMLEY, Andrew; COENS, Corneel; EFFICACE, Fabio et al.Journal of clinical oncology. 2007, Vol 25, Num 36, pp 5770-5776, issn 0732-183X, 7 p.Article

Hypofractionated external beam radiotherapy as retreatment for symptomatic non-small-cell lung carcinoma: An effective treatment?KRAMER, Gijsbert W. P. M; GANS, Steven; ULLMANN, Eric et al.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 5, pp 1388-1393, issn 0360-3016, 6 p.Article

Staging of non-small cell lung cancer: consensus, controversies and challengesVAN MEERBEECK, Jan P.Lung cancer. 2001, Vol 34, pp S95-S107, issn 0169-5002, SUP2Conference Paper

Progression-free survival rate as primary end point for phase II cancer clinical trials : Application to mesothelioma-the EORTC lung cancer groupFRANCART, Julie; LEGRAND, Catherine; SYLVESTER, Richard et al.Journal of clinical oncology. 2006, Vol 24, Num 19, pp 3007-3012, issn 0732-183X, 6 p.Article

Transesophageal Endoscopic Ultrasound with Fine Needle Aspiration in the Preoperative Staging of Malignant Pleural MesotheliomaTOURNOY, Kurt G; BURGERS, Sjaak A; ANNEMA, Jouke T et al.Clinical cancer research (Print). 2008, Vol 14, Num 19, pp 6259-6263, issn 1078-0432, 5 p.Article

Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: A prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923ARDIZZONI, Andrea; TJAN-HEIJNEN, Vivianne C. G; LEGRAND, Catherine et al.Journal of clinical oncology. 2002, Vol 20, Num 19, pp 3947-3955, issn 0732-183X, 9 p.Article

Multimodal management of malignant pleural mesothelioma: where are we today?VAN SCHIL, Paul E; OPITZ, Isabelle; WEDER, Walter et al.The European respiratory journal. 2014, Vol 44, Num 3, pp 754-764, issn 0903-1936, 11 p.Article

Mediastinoscopy vs Endosonography for Mediastinal Nodal Staging of Lung Cancer: A Randomized TrialANNEMA, Jouke T; VAN MEERBEECK, Jan P; DE RYCK, Frederick et al.JAMA, the journal of the American Medical Association. 2010, Vol 304, Num 20, pp 2245-2252, issn 0098-7484, 8 p.Article

Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitorsROLFO, Christian; GIOVANNETTI, Elisa; TARON, Mìquel et al.Cancer treatment reviews. 2014, Vol 40, Num 8, pp 990-1004, issn 0305-7372, 15 p.Article

Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052)O'BRIEN, Mary E. R; GAAFAR, Rabab M; HASAN, Baktiar et al.European journal of cancer (1990). 2013, Vol 49, Num 13, pp 2815-2822, issn 0959-8049, 8 p.Article

EBUS-TBNA for the diagnosis of central parenchymal lung lesions not visible at routine bronchoscopyTOUMOY, Kurt G; RINTOUL, Robert C; VAN MEERBEECK, Jan P et al.Lung cancer. 2009, Vol 63, Num 1, pp 45-49, issn 0169-5002, 5 p.Article

Unexpected response of a pulmonary blastoma on radiotherapy: a case report and review of the literatureSURMONT, Veerle F; VAN KLAVEREN, Rob J; NOWAK, Peter J. C. M et al.Lung cancer. 2002, Vol 36, Num 2, pp 207-211, issn 0169-5002, 5 p.Article

A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03)GAAFAR, Rabab M; SURMONT, Veerle F; SCAGLIOTTI, Giorgio V et al.European journal of cancer (1990). 2011, Vol 47, Num 15, pp 2331-2340, issn 0959-8049, 10 p.Article

Endoscopic Ultrasound Reduces Surgical Mediastinal Staging in Lung Cancer : A Randomized TrialTOURNOY, Kurt G; DE RYCK, Frederic; VANWALLEGHEM, Lieve R et al.American journal of respiratory and critical care medicine. 2008, Vol 177, Num 5, pp 531-535, issn 1073-449X, 5 p.Article